Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 6, 2002 - Issue 5
Submit an article Journal homepage
63
Views
7
CrossRef citations to date
0
Altmetric
Miscellaneous

Antischizophrenic activity independent of dopamine D2 blockade

Hans O Kalkman Novartis Pharma AG, Research Nervous System, Building WSJ-360-405, CH-4002 Basel, Switzerland
Pages 571-582 | Published online: 25 Feb 2005

  • LILLIOJA S, MOTT DM, HOWARD BV et al.: Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N. Engl. J. Med. (1988) 318:1217–1225.
  • ••Underscores the importance of insulinresistance in Type 2 diabetes.
  • DEFRONZO RA, BONADONNA RC, FERRANNINI E: Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 15:318–368.
  • LILLIOJA S, MOTT DM, SPRAUL M et al.: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N. Engl. J. Med. (1993) 329:1988–1992.
  • WARRAM JH, MARTIN BC, KROLEWSKI AS, SOELDNER JS, KAHN CR: Slow glucose removal rate and hyperinsulinemia precede the development of Type II diabetes in the offspring of diabetic parents. Ann. Intern. Med. (1990) 113:909–915.
  • PESSIN JE, SALTIEL AR: Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. (2000) 106:165–169.
  • SALTIEL AR, KAHN RC: Insulin signalling and the regulation of glucose and lipid metabolism. Nature (2001) 414:799–806.
  • ••Excellent review of the cellularmechanisms mediating the action of insulin.
  • LITHERLAND GJ, HAJDUCH E, HUNDAL HS: Intracellular signalling mechanisms regulating glucose transport in insulin-sensitive tissues (review). Mel Membr. Biol. (2001) 18:195–204.
  • BRUNING JC, GAUTAM D, BURKS DJ et al.: Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 289:2122–2125.
  • SALTIEL AR, PESSIN JE: Insulin signaling pathways in time and space. Trends Cell Biol. (2002) 12:65–71.
  • FERRANNINI E, BARRETT EJ, BEVILACQUA S, DEFRONZO RA: Effect of fatty acids on glucose production and utilization in man. I Clin. Invest. (1983) 72:1737–1747.
  • •An excellent demonstration of the link between fatty acids and insulin resistance.
  • MCGARRY JD: What if Minkowski had been ageusic? An alternative angle on diabetes. Science (1992) 258:766–770.
  • RANDLE PJ, GARLAND PB, HALES CN, NEWSHOLME EA: The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet (1963) 1:785–789.
  • ••The Randle hypothesis.
  • RODEN M, PRICE TB, PERSEGHIN G et al.: Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. (1996) 97:2859–2865.
  • ••Challenges the Randle hypothesis:documents defect in glucose transport and or oxidation.
  • DRESNER A, LAURENT D, MARCUCCI M et al: Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. (1999) 103:253–259.
  • ••Challenges the Randle hypothesis:documents defect in glucose transport.
  • PETERSEN KF, HENDLER R, PRICE T etal.: 13C/31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes (1998) 47:381–386.
  • •Idem.
  • FEINGOLD KR, SOUED M, STAPRANS I et al: Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. Clin. Invest. (1989) 83:1116–1121.
  • HIGUCHI Y, HERRERA P, MUNIESA P etal.: Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. (1992) 176:1719–1731.
  • RABINOVITCH A: An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev (1998) 14:129–151.
  • HOTAMISLIGIL GS: The role of TNFalpha and TNF receptors in obesity and insulin resistance. I Intern. Med. (1999) 245:621–625.
  • FLIER JS: Diabetes. The missing link with obesity? Nature (2001) 409:292–293.
  • WEISBERG SP, MCCANN D, DESAI M, ROSENBAUM M, LEIBEL RL, FERRANTE AW Jr: Obesity is associated with macrophage accumulation in adipose tissue../. Clin. Invest. (2003) 112: 1796-1808.
  • •Demonstrates chronic inflammation in adipose tissue of obese subjects.
  • XU H, BARNES GT, YANG Q etal.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. (2003) 112:1821–1830.
  • •Demonstrates chronic inflammation In adipose tissue of obese subjects.
  • BODEN G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes (1997) 46:3–10.
  • AGUIRRE V, UCHIDA T, YENUSH L, DAVIS R, WHITE MF: The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). Biol. Chem. (2000) 275:9047–9054.
  • RYDEN M, DICKER A, VAN HARMELEN V et al: Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. J. Biol. Chem. (2002) 277:1085–1091.
  • HIROSUMI J, TUNCMAN G, CHANG L et al: A central role for JNK in obesity and insulin resistance. Nature (2002) 420:333–336.
  • ••Elegant demonstration of the involvementof JNK-1 in obesity-associated insulin resistance.
  • WILLIAMSON R: On the treatment of glycosuria and diabetes mellitus with sodium salicylate. BE Med. J. (1901) 1:760–762.
  • YIN MJ, YAMAMOTO Y, GAYNOR RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature (1998) 396:77–80.
  • KIM JK, KIM YJ, FILLMORE JJ et al: Prevention of fat-induced insulin resistance bysalicylate.j Clin. Invest. (2001) 108:437–446.
  • HUNDAL RS, PETERSEN KF, MAYERSON AB etal.: Mechanism by which high-dose aspirin improves glucose metabolism in Type 2 diabetes.' Clin. Invest. (2002) 109:1321–1326.
  • PERSEGHIN G, SCIFO P, DE COBELLI F et al: Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of Type 2 diabetic parents. Diabetes (1999) 48: 1600-1606.
  • KRSSAK M, FALK PETERSEN K, DRESNER A et al.: Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia (1999) 42:113–116.
  • PETERSEN KF, BEFROY D, DUFOUR S et al.: Mitochondrial dysfunction in the elderly: possible role in insulin-resistance. Science (2003) 300:1140–1142.
  • ••Documents that show significantmitochondrial oxidative capacity In insulin-resistant elderly subjects.
  • PETERSEN KF, DUFOUR S, BEFROY D, GARCIA R, SHULMAN GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N Engl. J. Med. (2004) 350:664–671.
  • ••Documents that show significant decreaseIn mitochondrial oxidative capacity in insulin-resistant young subjects with a family history of Type 2 diabetes. May represent one of the earliest and perhaps most critical abnormalities.
  • YAO X, CHANG AY, BOULPAEP EL, SEGAL AS, DESIR GV: Molecular cloning of a glibenclamide-sensitive, voltage-gated potassium channel expressed in rabbit kidney. I Clin. Invest. (1996) 97:2525–2533.
  • CAHALAN MD, CHANDY KG, GRISSMER S: Potassium Channels in Development, Activation, and Disease in T Lymphocytes. Current Topics in Membranes (1991) 39:357–394.
  • GHANSHANI S, WULFF H, MILLER MJ et al.: Up-regulation of the IKCal Potassium Channel during T-cell Activation. Molucular Mechanisms and Functional Consequences. J. Biol. Chem. (2000) 275:37137–37149.
  • LEVITE M, CAHALON L, PERETZ A et al: Extracellular K(÷) and opening of voltage-gated potassium channels activate T cell integrin function: physical and functional association between Kv1.3 channels and betal integrins../. Exp. Med. (2000) 191:1167–1176.
  • MOURRE C, CHERNOVA MN, MARTIN-EAUCLAIRE MF et al.: Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits. I. Pharmacol Exp. Ther. (1999) 291:943–952.
  • JACOB A, HURLEY IR, GOODWIN LO, COOPER GW, BENOFF S: Molecular characterization of a voltage-gated potassium channel expressed in rat testis. Mol Hum. Reprod. (2000) 6:303–313.
  • ARKETT SA, DIXON J, YANG JN, SAKAI DD, MINKIN C, SIMS SM: Mammalian osteoclasts express a transient potassium channel with properties of Kv1.3.Receptors Channels (1994) 2:281–293.
  • KOMAROVA SV, DIXON SJ, SIMS SM: Osteoclast ion channels: potential targets for antiresorptive drugs. Curr. Pharm. Des. (2001) 7:637–654.
  • WARNTGES S, FRIEDRICH B, HENKE G et al: Cerebral localization and regulation of the cell volume-sensitive serum- and glucocorticoid-dependent kinase SGKl. Pflugers Arch. (2002) 443:617–624.
  • LANG F, UHLEMANN AC, LEPPLE-WIENHUES A et al.: Cell volume regulatory mechanisms in apoptotic cell death. Herz. (1999) 24:232–235.
  • KALMAN K, PENNINGTON MW, LANIGAN MD et al: ShK-dap22, a potent Kv1.3-specific immunosuppressive polypeptide Biol Chem. (1998) 273(49):32697–32707.
  • FADOOL DA, TUCKER K, PHILLIPS JJ,SIMMEN JA: Brain insulin receptor causes activity-dependent current suppression in the olfactory bulb through multiple phosphorylation of Kv1.3.j Neurophysiol (2000) 83:2332–2348.
  • BOWLBY MR, FADOOL DA, HOLMES TC, LEVITAN IB: Modulation of the kv1.3 potassium channel by receptor tyrosine kinases. J. Gen. Physiol (1997) 110:601–610.
  • XU J, KONI PA, WANG P et al: The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight. Hum. Mol Genet. (2003) 12:551–559.
  • ••Documents the role of Kv1.3 in bodyweight regulation and overall energy balance.
  • XU J, KONI PA, WANG P et al: The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc. Natl. Acad. Sci. USA (2004) 101:3112–3117.
  • MANCHEM VP, GOLDFINE ID, KOHANSKI RA et al: A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo. Diabetes (2001) 50:824–830.
  • BROWN H, KOZLOWSKI R, PERRY H: The importance of ion channels for macrophage and microglial activation in vitro. Glia (1998) 22:94–97.
  • DECOURSEY TE, CHANDY KG, GUPTA S, CAHALAN MD: Voltage-Dependent Ion Channels in T-Lymphocytes. I Neuroimmunol (1985) 10:71–95.
  • MATTESON DR, DEUTSCH C: K channels in T lymphocytes: a patch clamp study using monoclonal antibody adhesion. Nature (1984) 307:468–471.
  • KOO GC, BLAKE JT, SHAH K et al: Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Immunol (1999) 197:99–107.
  • BEETON C, WULFF H, BARBARIA J et al: Selective blockade of T lymphocyte K(÷) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Nat!. Acad. Li. USA (2001) 98:13942–13947.
  • ATTALI B, HONORÉ E, LESAGE F, LAZDUNSKI M, BARHANIN J: Regulation of a major cloned voltage-gated K+ channel from human T lymphocytes. FEBS Lett. (1992) 303:229–232.
  • SZABO I, BOCK J, JEKLE A et al: A novel potassium channel in lymphocyte mitochondria. J. Biol. Chem. (2005).
  • ••Demonstrates presence of Kv1.3 in innermitochondrial membrane and effect of channel inhibition on mitochondrial membrane voltage.
  • ZISMAN A, PERONI OD, ABEL ED et al.: Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. (2000) 6:924–928.
  • WOJTASZEWSKI JF, HIGAKI Y, HIRSHMAN MF et al: Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice../. Clin. Invest. (1999) 104:1257–1264.
  • RICHTER EA, DERAVE W, WOJTASZEWSKI JF: Glucose, exerciseand insulin: emerging concepts. Physic] (2001) 535:313–322.
  • MU J, BROZINICK JT Jr, VALLADARES 0, BUCAN M, BIRNBAUM MJ: A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mel Cell. (2001) 7:1085–1094.
  • THORELL A, HIRSHMAN MF, NYGREN J et al.: Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am. .1 Physic]. (1999) 277:E733–E741.
  • HAYASHI T, HIRSHMAN ME DUFRESNE SD, GOODYEAR LJ: Skeletal muscle contractile activity in vitro stimulates mitogen-activated protein kinase signaling. Am.,/ Physic]. (1999) 277:C701–C707.
  • MACDONALD PE, HA XF, WANG J et al.: Members of the Kyl and Kv2 voltage-dependent K(+) channel families regulate insulin secretion. Mel Endocrine]. (2001) 15:1423–1435.
  • CHUTKOW WA, SAMUEL V, HANSEN PA, PU J et al: Disruption of Sur2-containing KATP channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc. Nati Acad. Sci. USA (2001) 98:11760–11764.
  • WASADA T, YANO T, OHTA M et al: ATP-sensitive potassium channels modulate glucose transport in cultured human skeletal muscle cells. Endocr. J. (2001) 48:369–375.
  • KALMAN K, PENNINGTON MW, LANIGAN MD et al: ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. Biol. Chem. (1998) 273:32697–32707.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.